Contact Us
Drug Search Results
More Filters [+]

Fluoroquinolone

Alternative Names: fluoroquinolone
Latest Update: 2024-05-14
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: TOP2 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous,Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Pakistan

Approved Indications: None

Known Adverse Events: None

Company: Johnson & Johnson
Company Location: NEW BRUNSWICK NJ 08933
Company CEO: Joaquin Duato
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fluoroquinolone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Prostatitis

Phase 3: Chronic Obstructive Pulmonary Disease|Acquired Immunodeficiency Syndrome|Tuberculosis, Pulmonary|HIV Infections

Phase 2: Escherichia coli Infections|Pyelonephritis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
OptiRiMoxTB

P3

Recruiting

Tuberculosis, Pulmonary|HIV Infections|Acquired Immunodeficiency Syndrome

2025-12-31

FIRST

N/A

Enrolling by invitation

Clostridium Infections|Colitis

2024-06-30

ChiCTR2200059983

N/A

Not yet recruiting

Colorectal Cancer

2024-04-30

ChiCTR2300072349

N/A

Not yet recruiting

Sepsis

2024-04-15

Recent News Events

Date

Type

Title

05/14/2024

PubMed

 Comparative retrospective assessment of the effectiveness and risk factors of fluoroquinolones, cephalosporines and selective antibiotic prophylaxis for transrectal prostate biopsy.

05/01/2024

PubMed

 Physicochemical parameters affecting the adhesion of ciprofloxacin-resistant Escherichia coli to activated sludge.

04/22/2024

News Article

 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients

04/15/2024

News Article

 Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only

04/14/2024

PubMed

 Antibiotic Resistance in Salmonella typhi Strains Isolated From Patients in Pakistan: A Hospital Database Study.

03/25/2024

News Article

 Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension

03/22/2024

News Article

 CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions